[Adenocarcinoma of the uterine cervix in patients using hormonal contraceptives].
Among 360 patients with cervical cancer af stage I b to IV 26 (7.2%) primary adenocarcinomas were observed. 51 patients stated to use hormonal contraceptives. In this group the frequency of adenocarcinomas run to 19.6% (10 women) contrary to 7.8% in patients of the same age non using contraceptives. Morphological and clinical particularities of the adenocarcinoma in pill users are discussed. The early detection of the predominantly intracervically localized adenocarcinomas can only be improved by careful colposcopy combined with obligatory ecto- and endocervical cytological swabs and palpation of the cervix. Atypical bleedings in women using longterm hormonal contraceptives particularly of the gestagen prevailing type need special attention.
Erbstösser
E
E
Klinik für Gynäkologie und Geburtshilfe, Medizinischen Akademie Magdeburg.
Nieder
J
J
Adomat
K
K
D000230:Adenocarcinoma / Q000139:chemically induced* / Q000473:pathology; D000328:Adult; D002584:Cervix Uteri / Q000473:pathology; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009367:Neoplasm Staging; D012307:Risk Factors; D002583:Uterine Cervical Neoplasms / Q000139:chemically induced* / Q000473:pathology; D014626:Vaginal Smears
D003278:Contraceptives, Oral, Hormonal
Adenokarzinome der Cervix uteri bei Patientinnen mit Einnahme hormonaler Kontrazeptiva.